Stackhaus Research does not claim that any product has been evaluated or approved by the U.S
GLP-1 & GIP Mechanisms Incretin Comparative Review (PubMed, 2024) Two-Incretin Model: GLP-1 and GIP Receptor Signalling Across Pancreas, Brain, Liver, and Adipose Tissue A comparative review of GLP-1 and GIP receptor mechanisms published on PubMed in 2024 documented the complete receptor-level biology of both incretins across multiple tissues
Li T, Chandrashekar A, Beig A, Walker J, Hong JKY, Benet A, et al
This product contains caffeine and should not be used by those wishing to eliminate caffeine from their diet or in combination with caffeine or stimulants from other sources, including but not limited to coffee, tea, soda, or other dietary supplements and medications
However, it is not a magic weight-loss pill
It is essential to emphasize that tirzepatide does not replace thyroid hormone replacement therapy, does not reduce thyroid antibody levels, and does not modify the autoimmune process in Hashimoto's disease